SEC Form 3 · accession 0001193125-26-333373
Attovia Therapeutics, Inc. · ATTO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Attovia Therapeutics, Inc.
Officer — President and CEO · Director
Period of report
Aug 4, 2026
Accepted (ET)
Aug 4, 2026 · 7:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0002058707
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 87,843 | D | ||
| Common StockF1 | holding | — | — | — | 99,181 | I | By Trust | |
| Common StockF2 | holding | — | — | — | 116,103 | I | By Trust | |
| Common StockF3 | holding | — | — | — | 245,425 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $1.5793 | holding | — | — | — | — | Aug 16, 2033 | Common Stock | 23,437 | — | D |
| Stock Option (Right to Buy)F5 | $3.5302 | holding | — | — | — | — | May 8, 2034 | Common Stock | 409,709 | — | D |
| Stock Option (Right to Buy)F6 | $4.9237 | holding | — | — | — | — | May 17, 2035 | Common Stock | 370,290 | — | D |
Explanation of responses
- F1These shares are held by the TF 2025 Annuity Trust, of which the reporting person is the trustee.
- F2These shares are held by the TF 2026 Annuity Trust, of which the reporting person is the trustee.
- F3These shares are held by the Hai Fu Revocable Trust, of which the reporting person and Hai Fu are trustees.
- F4Vest with respect to 25% of the shares of common stock underlying the stock option on the one-year anniversary of June 2, 2023, and an additional 1/48th of the total shares underlying the stock option vest in equal monthly installments over three years, subject to continued service through such date.
- F5Vest with respect to 25% of the shares of common stock underlying the stock option on the one-year anniversary of May 9, 2024, and an additional 1/48th of the total shares underlying the stock option vest in equal monthly installments over three years, subject to continued service through such date.
- F6Vest with respect to 25% of the shares of common stock underlying the stock option on the one-year anniversary of May 18, 2025, and an additional 1/48th of the total shares underlying the stock option vest in equal monthly installments over three years, subject to continued service through such date.
Remarks
EX - 24.1 Power of Attorney